Fund Card

Fund Card

Tata India Pharma & Healthcare Fund-Reg(G)

As on Jun-24-2022 change fund
15.42  up0.04 (0.23%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2017-20182018-20192019-20202020-20212021-2022
NAV in Rs (as on 31-Mar-2022)8.359.098.9314.7317.18
Net Assets(Rs Crores) (as on 31-Mar-2022) 133.13 179.56 152.64 435.03 553.33
Scheme Returns(%)(Absolute)-9.687.51-2.1967.2416.04
B'mark Returns(%)(Absolute)-20.438.42-23.4574.669.75
Category Rank54/6224/7311/7549/7541/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2021-202216.843.710.97-4.64
2020-202125.0721.7811.24-2.68
2019-2020-4.661.784.39-2.98
2018-20192.446.80-4.444.15
2017-2018-4.38-6.159.58-6.86
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...14.69 
Dr. Reddy's Laboratories Ltd.11.24 
Cipla Ltd.11.04 
Apollo Hospitals Enterprise Ltd.6.60 
Alkem Laboratories Ltd.6.39 
Ipca Laboratories Ltd.5.64 
Fortis Healthcare Ltd.4.71 
Lupin Ltd.4.54 
JB Chemicals & Pharmaceuticals...3.30 
Krishna Institute of Medical S...3.02 

Category

Sector Funds

Launch Date

28-Dec-15

Scheme Benchmark

NA

AUM ( in Cr.)

508.15

portfolio price to book value

5.03

investing style?

Large Growth

fund manager?

Meeta Shetty

inception date (regular plan)

28-Dec-15

expense ratio (regular plan) %

2.37

Alpha [%]

-0.04

Beta [%]

0.55

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs76.08
Hospital & Healthcare Services16.41
Miscellaneous2.87
Insurance0.50

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015508.152.79-2.59-10.31-7.4521.8512.33NA6.90BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,691.612.97-2.42-10.73-7.1626.62NANA19.13BUYSIP
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,178.572.94-3.74-10.78-9.2225.81NANA20.28BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20182,316.082.10-1.53-8.87-10.2823.78NANA15.99BUYSIP
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,515.922.83-1.72-10.33-12.3723.2715.4716.3419.79BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,638.302.90-2.17-9.82-10.4923.1110.0615.1014.75BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005706.493.21-2.99-11.51-12.1121.4911.0413.1816.90BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201962.333.33-2.77-10.88-12.7618.40NANA15.51BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019470.262.84-2.34-11.03-10.68NANANA17.95BUYSIP
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021158.903.02-1.64-9.31NANANANA-13.62BUYSIP

Copyright © 2022 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974